Giacomo Mazzoli
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Adjuvant chemotherapy in stage I triple-negative breast cancer: A systematic review and meta-analysis of survival outcomes.
Journal: Cancer treatment reviews
Published: February 14, 2026
Real-world effectiveness of CDK4/6 inhibitors in older patients with HR+/HER2- advanced breast cancer: a sub-analysis of the multicenter, PALMARES-2 study.
Journal: Breast (Edinburgh, Scotland)
Published: December 22, 2025
Effectiveness comparison of first-line CDK4/6 inhibitors in patients with hormone-positive HER2-negative advanced breast cancer according to tumor histology: a sub-analysis of the real-world, multicenter, Italian study PALMARES-2.
Journal: Breast (Edinburgh, Scotland)
Published: November 12, 2025
Event-Free Survival After Stereotactic Body Radiation Therapy for Oligoprogressive Metastatic Breast Cancer.
Journal: Clinical breast cancer
Published: September 28, 2025
Sex and outcomes of patients with microsatellite instability-high and BRAF V600E mutated metastatic colorectal cancer receiving immune checkpoint inhibitors.
Journal: Journal for immunotherapy of cancer
Published: January 24, 2025
Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 09, 2024
Comparative efficacy of PD-1 blockade in patients with dMMR/MSI-H metastatic colorectal or gastric cancer: a global retrospective study.
Journal: ESMO gastrointestinal oncology
Published: February 01, 2024
Mytomicin-C, Metronomic Capecitabine, and Bevacizumab in Patients With Unresectable or Relapsed Pseudomyxoma Peritonei of Appendiceal Origin.
Journal: Clinical colorectal cancer
Published: February 12, 2023
Tumour mutational burden as a biomarker in patients with mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer treated with immune checkpoint inhibitors.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 06, 2023
Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer.
Journal: Journal for immunotherapy of cancer
Published: December 14, 2022
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases.
Journal: JCO precision oncology
Published: November 10, 2022
Last Updated: 09/26/2026